de Boer W J, Mannes G P, Meuzelaar J J, Brenken U P, van der Bij W, Loef B
Afd. Thoraxchirurgie, Academisch Ziekenhuis, Groningen.
Ned Tijdschr Geneeskd. 1996 Jun 29;140(26):1362-6.
To describe the development of the lung transplantation programme in Groningen, and the results of single and bilateral lung transplantations in the first 75 consecutive patients, up to December 1995.
Retrospective.
Academic Hospital Groningen, the Netherlands.
The results of the lung transplantation programme were evaluated retrospectively.
In November 1990 the first unilateral lung transplantation was performed in Groningen in a patient with pulmonary fibrosis. In February 1991 a national lung transplantation programme for the Netherlands was instituted in Groningen by the government. Of 500 patients referred from all over the Netherlands from 1990 to December 1995, 75 were transplanted, 16 unilaterally and 59 bilaterally. The actuarial survival for all patients was 85% after 1 year and 72% after 2 years. After transplantation 16 patients died (21%) after 15 months follow-up (median). Early mortality (5%) was caused by graft failure, late mortality (16%) by chronic rejection and lymphoproliferative disease. The mean time on the transplantation waiting list was 9.3 months; it increased during the programme. The limiting factor for further expansion of the programme was caused by donor scarcity. The lungs from only 16% of the multiorgan donors reported by Eurotransplant to our centre could be transplanted.
The results of the lung transplantation programme in Groningen are good but with an increasing number of lung transplantation centres in the Eurotransplant region the further development of lung transplantation in the Netherlands will depend mainly on the availability of lung donors from the Netherlands.
描述格罗宁根肺移植项目的发展情况,以及截至1995年12月连续75例患者进行单肺和双肺移植的结果。
回顾性研究。
荷兰格罗宁根大学医学中心。
对肺移植项目的结果进行回顾性评估。
1990年11月,格罗宁根为一名肺纤维化患者实施了首例单肺移植手术。1991年2月,荷兰政府在格罗宁根启动了一项全国性肺移植项目。1990年至1995年12月期间,从荷兰各地转诊的500例患者中,75例接受了移植,其中16例为单肺移植,59例为双肺移植。所有患者术后1年的实际生存率为85%,2年为72%。随访(中位数)15个月后,16例患者死亡(21%)。早期死亡率(5%)由移植肺功能衰竭引起,晚期死亡率(16%)由慢性排斥反应和淋巴增殖性疾病引起。患者在移植等待名单上的平均时间为9.3个月,且在项目实施过程中有所增加。项目进一步扩大的限制因素是供体短缺。欧洲移植组织报告给我们中心的多器官供体中,只有16%的肺可用于移植。
格罗宁根肺移植项目的结果良好,但随着欧洲移植区域肺移植中心数量的增加,荷兰肺移植的进一步发展将主要取决于荷兰肺供体的可获得性。